pocketful logo light
pocketful logo light
Glaxosmithkline Pharmaceuticals Ltd logo

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO BSE: 500660

₹2346.80

(1.78%)

Mon, 25 May 2026, 10:00 pm

mtf coin illustrationMTF 5x

Glaxosmithkline Pharmaceuticals Technical Analysis

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic2411.302364.302337.602317.302290.602270.302223.30
Fibonacci2364.302346.352335.252317.302299.352288.252270.30
Camarilla2323.832319.522315.212317.302306.592302.282297.97

Pivots Level: Classic

R3

+94

2411.30

R2

+47

2364.30

R1

+20.30

2337.60

2317.30
2317.30
Pivot Point
LTP: 2300

S1

-26.70

2290.60

S2

-47

2270.30

S3

-94

2223.30

Pivots Level: camarilla

FibonacciCamarilla

R3

+6.53

2323.83

R2

+2.22

2319.52

R1

+2.09

2315.21

2317.30
2317.30
Pivot Point
LTP: 2300

S1

-10.71

2306.59

S2

-15.02

2302.28

S3

-19.32

2297.97

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    2304.57

  • 20-EMA

    2308.57

  • 30-EMA

    2311.76

  • 50-EMA

    2318.33

  • 100-EMA

    2336.00

  • 200-EMA

    2362.99

Technical Indicators

Period

Value

  • ADX

    17.64

  • ADX+DI

    11.89

  • ADX+DI[1]

    12.49

  • ADX-DI

    23.58

  • ADX-DI[1]

    23.76

  • AO

    -10.21

  • AO[1]

    -9.10

  • AO[2]

    -8.28

  • BBPower

    -12.88

  • CCI20

    -125.65

  • CCI20[1]

    -125.11

  • HullMA9

    2299.03

  • Ichimoku.BLine

    2319

  • MACD.macd

    -5.00

  • MACD.signal

    -4.23

  • Mom

    -8.90

  • Mom[1]

    -10

  • RSI

    37.53

  • RSI[1]

    37.53

  • Rec.BBPower

    0

  • Rec.HullMA9

    1

  • Rec.Ichimoku

    0

  • Rec.Stoch.RSI

    0

  • Rec.UO

    0

  • Rec.VWMA

    -1

  • Rec.WR

    1

  • Recommend.All

    -0.35

  • Recommend.MA

    -0.80

  • Recommend.Other

    0.09

  • Stoch.D

    11.72

  • Stoch.D[1]

    27.10

  • Stoch.K

    9.33

  • Stoch.K[1]

    24.70

  • Stoch.RSI.K

    12.38

  • UO

    40.41

  • VWMA

    2307.47

  • W.R

    -88

  • close

    2300

Glaxosmithkline Pharmaceuticals Ltd Technical Analysis

Glaxosmithkline Pharmaceuticals Ltd technical analysis is gaining attention among traders and investors tracking Glaxosmithkline Pharmaceuticals Ltd Technical Analysis trends in the Indian stock market. Glaxosmithkline Pharmaceuticals Ltd (NSE: GLAXO, BSE: 500660) is currently trading at ₹2346.80, showing a -1.78% move as of Mon, May 25, 2026.

This detailed Glaxosmithkline Pharmaceuticals Ltd technical analysis covers support & resistance levels, moving averages, indicators, and overall market sentiment to help investors make informed decisions.

Glaxosmithkline Pharmaceuticals Ltd Stock Overview

Glaxosmithkline Pharmaceuticals Ltd operates in the Health technology sector under the Pharmaceuticals: major industry. With a market capitalization of ₹404.69B and a PE ratio of 38.38, Glaxosmithkline Pharmaceuticals Ltd remains a key stock to watch in Glaxosmithkline Pharmaceuticals Ltd Technical Analysis searches.

Key Metrics

  • Market Cap: ₹404.69B
  • PE Ratio: 38.38
  • Dividend Yield: 1.76
  • Sector: Health technology
  • Industry: Pharmaceuticals: major

These fundamentals play an important role in Glaxosmithkline Pharmaceuticals Ltd technical analysis and valuation tracking.

Glaxosmithkline Pharmaceuticals Ltd Support and Resistance Levels

Classic Pivot Levels

In Glaxosmithkline Pharmaceuticals Ltd technical analysis, pivot levels help identify potential reversal and breakout zones.

  • Resistance 3: 2912.07
  • Resistance 2: 2644.07
  • Resistance 1: 2490.23
  • Pivot Point: 2376.07
  • Support 1: 2222.23
  • Support 2: 2108.07
  • Support 3: 1840.07

Conditional Insight

Glaxosmithkline Pharmaceuticals Ltd technical analysis suggests a bearish to neutral trend as the price is below the pivot point. Immediate support is seen near 2222.23 and 2108.07.

Fibonacci Levels Analysis

Fibonacci levels are widely used in Glaxosmithkline Pharmaceuticals Ltd technical analysis to identify retracement zones.

  • Fibonacci R3: 2644.07
  • Fibonacci R2: 2541.69
  • Fibonacci R1: 2478.44
  • Fibonacci Pivot: 2376.07
  • Fibonacci S1: 2273.69
  • Fibonacci S2: 2210.44
  • Fibonacci S3: 2108.07

Glaxosmithkline Pharmaceuticals Ltd technical analysis indicates consolidation between Fibonacci pivot and resistance zones.

Glaxosmithkline Pharmaceuticals Ltd Moving Average Analysis

Moving averages are key indicators in Glaxosmithkline Pharmaceuticals Ltd technical analysis for identifying trend direction.

  • 10 EMA: 2359.69
  • 20 EMA: 2382.72
  • 30 EMA: 2393.06
  • 50 EMA: 2409.11
  • 100 EMA: 2454.43
  • 200 EMA: 2530.50

Trend Logic

Glaxosmithkline Pharmaceuticals Ltd technical analysis indicates bearish pressure, with price trading below key moving averages.

Long-term trend in Glaxosmithkline Pharmaceuticals Ltd technical analysis remains positive above 200 EMA.

Glaxosmithkline Pharmaceuticals Ltd Technical Indicators Overview

Momentum Indicators

  • RSI: 36.23
  • MACD: -22.65
  • Signal: -8.29
  • ADX: 16.06
  • Momentum: -136.10

RSI Logic

Glaxosmithkline Pharmaceuticals Ltd technical analysis shows RSI in neutral range, suggesting consolidation.

MACD Logic

Glaxosmithkline Pharmaceuticals Ltd technical analysis indicates bearish momentum with MACD below signal line.

Glaxosmithkline Pharmaceuticals Ltd Overall Recommendation

  • Overall Recommendation Score: -0.40
  • Moving Average Recommendation: -0.80
  • Other Indicators Recommendation: 0

Overall Glaxosmithkline Pharmaceuticals Ltd technical analysis sentiment remains neutral with mixed signals.

Glaxosmithkline Pharmaceuticals Ltd Technical Analysis Conclusion

Glaxosmithkline Pharmaceuticals Ltd technical analysis suggests that traders should closely monitor price action around ₹2346.80 and key pivot level 2376.07. Breakouts above resistance or breakdown below support will define the next trend in Glaxosmithkline Pharmaceuticals Ltd technical analysis.

Investors searching for Glaxosmithkline Pharmaceuticals Ltd Technical Analysis should track moving averages, RSI levels, and volume trends to identify potential entry and exit opportunities. As market conditions change, Glaxosmithkline Pharmaceuticals Ltd technical analysis will continue to play a crucial role in short-term trading and long-term investment strategies.